Next Article in Journal
The Domestication of Wild Boar Could Result in a Relaxed Selection for Maintaining Olfactory Capacity
Previous Article in Journal
Salivary Gland Sonography in Patients with Primary Fibromyalgia—A Pilot Study
Previous Article in Special Issue
Overexpression of BQ323636.1 Modulated AR/IL-8/CXCR1 Axis to Confer Tamoxifen Resistance in ER-Positive Breast Cancer
 
 
Correction to Life 2022, 12(1), 93.
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Tsoi et al. Overexpression of BQ323636.1 Modulated AR/IL-8/CXCR1 Axis to Confer Tamoxifen Resistance in ER-Positive Breast Cancer. Life 2022, 12, 93

1
Department of Pathology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China
2
Department of Clinical Oncology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China
*
Author to whom correspondence should be addressed.
Life 2024, 14(8), 1044; https://doi.org/10.3390/life14081044
Submission received: 27 May 2024 / Accepted: 28 June 2024 / Published: 22 August 2024
(This article belongs to the Special Issue Drug Resistance, Molecular Oncology and Genetics of Breast Cancer)

Error in Figure

In the original publication (doi: 10.3390/life12010093; [1]), there was a mistake in Figure 8a as published. We provided photomicrograph captions to illustrate what high- and low- nuclear BQ expressing breast cancer samples in tissue microarray look like (Figure 8a). For the high nuclear BQ expression, we inadvertently made use of the same case we had previously chosen as illustration in our previous publication (Figure 4A, PMID: 29420220), as this was probably the best illustrative core for high nuclear BQ expression. The purpose of these figures is merely illustrative, providing an example of high-and low-staining samples, without deriving from it any biological data or information. In order not to infringe on potential copyright issues, relating to our previous publication PMID: 29420220, we now replace high BQ expression with a new figure. The corrected Figure 8a appears below.
Life 14 01044 i001
The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Reference

  1. Tsoi, H.; Shi, L.; Leung, M.-H.; Man, E.P.S.; So, Z.-Q.; Chan, W.-L.; Khoo, U.-S. Overexpression of BQ323636.1 Modulated AR/IL-8/CXCR1 Axis to Confer Tamoxifen Resistance in ER-Positive Breast Cancer. Life 2022, 12, 93. [Google Scholar] [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Tsoi, H.; Shi, L.; Leung, M.-H.; Man, E.P.S.; So, Z.-Q.; Chan, W.-L.; Khoo, U.-S. Correction: Tsoi et al. Overexpression of BQ323636.1 Modulated AR/IL-8/CXCR1 Axis to Confer Tamoxifen Resistance in ER-Positive Breast Cancer. Life 2022, 12, 93. Life 2024, 14, 1044. https://doi.org/10.3390/life14081044

AMA Style

Tsoi H, Shi L, Leung M-H, Man EPS, So Z-Q, Chan W-L, Khoo U-S. Correction: Tsoi et al. Overexpression of BQ323636.1 Modulated AR/IL-8/CXCR1 Axis to Confer Tamoxifen Resistance in ER-Positive Breast Cancer. Life 2022, 12, 93. Life. 2024; 14(8):1044. https://doi.org/10.3390/life14081044

Chicago/Turabian Style

Tsoi, Ho, Ling Shi, Man-Hong Leung, Ellen P. S. Man, Zi-Qing So, Wing-Lok Chan, and Ui-Soon Khoo. 2024. "Correction: Tsoi et al. Overexpression of BQ323636.1 Modulated AR/IL-8/CXCR1 Axis to Confer Tamoxifen Resistance in ER-Positive Breast Cancer. Life 2022, 12, 93" Life 14, no. 8: 1044. https://doi.org/10.3390/life14081044

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop